City of Hope scientists have combined two immunotherapies—an oncolytic virus and chimeric antigen receptor CAR T-cell therapy—to target and eradicate solid tumors that are otherwise difficult to treat with CAR T therapy alone, according to a study in Science Translational Medicine.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
